Článek v časopise Publikováno 2017

Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas

Magdalena Houdová Megová, Jiří Drábek, Z. Dwight, Radek Trojanec, Vladimíra Koudeláková, Jana Vrbková, Ondřej Kalita, Soňa Mlčochová, Miroslava Rabčanová, Marián Hajdúch

Klinická onkologie 30(5), 361-371 (2017)

Citovat

2017 Rok

Citace publikace

HOUDOVÁ MEGOVÁ, M., J. DRÁBEK, Z. DWIGHT, R. TROJANEC, V. KOUDELÁKOVÁ, J. VRBKOVÁ, O. KALITA, S. MLČOCHOVÁ, M. RABČANOVÁ, M. HAJDÚCH: Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas. Klinická onkologie. 2017, 30(5), 361-371, ISSN: 0862-495X.

Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas

Citace publikace

Podrobnosti

Autoři z EATRIS